DECHEMA visits Berlin-Buch: Trading in cells - Lab cultures, patients, and the promise of applications


13:00 Registration Open

13:30 Welcome remarks
Christina Quensel, CEO of BBB Management GmbH Campus Berlin-Buch

13:45 Stem cell-based treatment and modeling of neuropsychiatric disease
Steven A. Goldman, University of Rochester, Medical Center/ University of Copenhagen, Center for Basic and Translational Neuroscience

14:15 Transformation of a biotech company to a developer of innovative cell-based therapeutics
Kai Pinkernell, Medigene AG

14:30 A clinical Phase I trial of MAGE-A1-specific T cell receptor gene therapy
Elisa Kieback, Max Delbrück Center for Molecular Medicine

14:45 Purification of stable human Treg for improved generation of genetically engineered CAR-Treg
Anna Nowak, Charité / German Rheumatism Research Centre Berlin (DRFZ)

15:00 Expansion of Immunocells for Therapy in a Perfusion Bioreactor System
Dirk Gustavus, Zellwerk GmbH

15:15 Break with Poster session

16:45 Combined ex vivo cell and gene therapy of epidermolysis bullosa by transgenic epidermal stem cells
Michele De Luca, University of Modena, Centre for Regenerative Medicine

17:15 Defining the manufacturing design of an autologous cell-based therapy for cartilage repair to improve its efficacy
Giulietta Roël, co.don AG

17:30 BECAT - a new research cluster for cell and gene therapies
Petra Reinke, Berlin-Brandenburg Center for Regenerative Therapies BCRT

17:45 Goodbye flat biology - the use of 3D cell cultures as pre-clinical models
Christian Regenbrecht, cpo - cellular phenomics & oncology GmbH

18:00 Get-together

Daniel Besser, German Stem Cell Network (GSCN)  c/o Max Delbrück Center for Molecular Medicine (MDC)

The colloquium is organised by Berlin Partner for Business and Technology GmbH, Campus Berlin-Buch, and supported by DECHEMA e.V.

Jetzt Mitglied werden